Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune disorders primarily characterised by progressive muscle weakness and inflammation, but with potential involvement ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust ...

Early-onset IBM challenges age-centric diagnostic criteria, with symptoms appearing in patients younger than 46. Younger IBM patients show a higher rate of mitochondrial DNA mutations, indicating ...

Despite modern medical therapies, multiorgan idiopathic inflammatory myopathies (IIM) are associated with reduced quality of life and life expectancy. A systematic review of all published ...

Idiopathic inflammatory myopathies (IIMs) comprise a group of inflammatory disorders in which there is chronic inflammation of skeletal muscle. This is then followed by muscle weakness. One type of ...

History gathering should solicit the patient’s abilities or limitations with these activities of daily living (ADLs). The patient may have mild arthralgias. Lungs are the most common extra muscular ...

Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be initiated in the first quarter of 2025 Company plans to report initial clinical data from Phase ...

The final diagnosis was autoimmune inflammatory myositis of the necrotizing myopathy subtype. Annabelle was treated with a loading dose of methylprednisolone sodium succinate (1 g intravenously daily ...

The incidence of serious adverse events did not differ significantly between combo therapy and monotherapy in patients with immune-mediated inflammatory diseases. However, specific combinations such ...

Few controlled studies are available to guide treatment strategies in dermatomyositis (DM), and treatment recommendations for DM have mostly been based on case series, case reports, and expert opinion ...

Barcelona, Spain, has taken center stage in global rheumatology by hosting the 2025 Annual Meeting of the European Alliance of Associations for Rheumatology (EULAR). “This is the world’s largest ...